News
Source-attributed headlines with timestamps and links to the companies and crypto markets they mention.
Latest Coverage
30 headlines
Filed: 2026-09-08 AccNo: 0000930413-26-002858 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-08 AccNo: 0000831259-26-000038 Size: 143 KB Item 8.01: Other Events
Filed: 2026-09-08 AccNo: 0001193125-26-385362 Size: 24 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
The article argues that the current AI buildout, representing the largest industrial expansion since 19th-century railroads, is fundamentally different from the 1990s internet bubble. Unlike the dot-com era where 90% of fiber infrastructure sat unused and 75% of IPOs operated at losses, today's AI companies are profitable, have reasonable valuations, and their hardware is in high demand with premium pricing. This suggests the AI boom has a stronger economic foundation than the internet bubble.
Pomerantz LLP has filed a class action lawsuit against Capricor Therapeutics for alleged securities fraud related to its Deramiocel BLA submission to the FDA. The FDA's briefing documents revealed that Capricor altered its statistical analysis plan one day before data unblinding without FDA approval, leading the FDA to deem the analyses as 'post-hoc and exploratory.' Following the FDA's negative assessment on July 27, 2026, Capricor's stock plummeted 64%, and an advisory committee voted 9-3 against the drug's efficacy on July 30, 2026, causing an additional 36% stock decline.
Pomerantz Law Firm has filed a class action lawsuit against Flotek Industries (NYSE: FTK) alleging securities fraud. The lawsuit stems from Flotek's announcement of a $400M contract with Puerto Rico's Electric Power Authority (PREPA) on August 3, 2026, which was subsequently canceled on August 18, 2026. Wolfpack Research reported that the contract was terminated due to unauthorized use of another contractor's signature and federal regulatory concerns. Flotek's stock fell 20.01% on August 17 and an additional 5.72% on August 18. Investors have until October 26, 2026, to request Lead Plaintiff status.
Pomerantz Law Firm has filed class action lawsuits against Bloom Energy Corporation, Primoris Services Corporation, and Regeneron Pharmaceuticals, Inc., alleging securities fraud and unlawful business practices. The Bloom Energy lawsuit was triggered by a Hunterbrook Media report alleging the company relies on Chinese scandium in its supply chain, causing the stock to fall 5.67% on July 8, 2026. Investors have until September 28, 2026, to request Lead Plaintiff status.
Pomerantz LLP has filed a class action lawsuit against Wise Group plc (WSE) for alleged securities fraud and unlawful business practices. The lawsuit follows investigations by Brussels prosecutors into over €500 million in suspicious transactions involving potential money laundering, and U.S. regulators' denial of Wise's national trust bank license application due to deficiencies in anti-money laundering programs. Wise's stock declined significantly following these disclosures in June and July 2026. The deadline to join the class action is September 29, 2026.
Pomerantz LLP has filed a class action lawsuit against Megan Holdings Limited (NASDAQ: MGN) alleging securities fraud and stock manipulation. The complaint claims coordinated social media campaigns by stock promoters posing as financial advisors artificially inflated the stock price during the Class Period (September 26, 2025 - March 25, 2026). On March 26, 2026, Megan's stock collapsed 93.4% from $4.24 to $0.28 per share, triggering multiple NASDAQ trading halts. Investors who purchased shares during the IPO or Class Period are urged to contact the firm by the September 8, 2026 deadline to potentially serve as Lead Plaintiff.
Pomerantz Law Firm has filed class action lawsuits against Regeneron Pharmaceuticals, Capricor Therapeutics, and GPGI, Inc. for alleged securities fraud. The primary focus is on Regeneron, where a Phase III clinical trial for Fianlimab-Libtayo failed to meet its primary endpoint, causing the stock to decline significantly on two separate occasions in April and May 2026. Investors with losses are urged to contact the firm by September 14, 2026, to potentially become lead plaintiffs.
Qualcomm shares rose 8.7% following a partnership announcement with Amazon to develop custom AI chips for AWS data centers. Amazon also obtained a warrant to purchase up to 25 million Qualcomm shares at $161.26 per share, contingent on up to $60 billion in chip orders. The deal positions Qualcomm to capitalize on the AI data center buildout as smartphone market growth slows.
Pfizer stock surged nearly 14% in August following better-than-expected Q2 earnings (revenue $15B vs. $14.4B expected, EPS $0.77 vs. $0.68 expected) and raised full-year revenue guidance. The company also achieved regulatory victories with EMA validation for a Lyme disease treatment and FDA approval for an updated COVID vaccine. Despite investor impatience over the lack of new blockbuster products, the analyst views Pfizer as undervalued with a promising pipeline from recent acquisitions.
Reshoring in U.S. manufacturing often involves replacing imported components with domestic capacity rather than relocating entire factories. While reshoring offers benefits like faster delivery and supply chain resilience, U.S. manufacturers face significant price competition, with 94% of contract manufacturers citing price as the main reason for losing orders to imports. MP Materials exemplifies reshoring opportunities through its rare-earth magnet production expansion in Texas, supported by Pentagon guarantees. However, manufacturing construction spending has declined 32% since September 2024, suggesting investors should verify whether reshoring interest translates into actual orders and earnings growth.
CoreWeave shares gained 12% today despite no company-specific news, benefiting from a broader rally in the AI infrastructure sector. The gains were driven by Nebius's partnership announcement with Palantir, Department of Commerce investments in quantum computing companies, and Intel's processor price increase announcement. CoreWeave remains a volatile, high-risk stock with rapid revenue growth but massive losses due to heavy capital expenditures and debt servicing.
A class action lawsuit has been filed against GPGI, Inc. for alleged securities fraud following significant stock price declines. The company's Husky Technologies segment showed deteriorating financial performance with compressed margins and declining EBITDA, leading to substantial guidance cuts in May 2026. Investors have until September 14, 2026, to request Lead Plaintiff status.
Pomerantz LLP has filed a class action lawsuit against Hyliion Holdings Corp., alleging securities fraud and unlawful business practices. The lawsuit was triggered by a Pelican Way Research short report questioning the validity of Hyliion's $133 million non-binding letter of intent with VFG Holdings, citing concerns about VFG's legitimacy and funding. Following the report's publication on June 23, 2026, Hyliion's stock price fell 17.2% to $6.10 per share. Investors have until October 27, 2026, to request Lead Plaintiff status.
Filed: 2026-09-08 AccNo: 0001213900-26-098107 Size: 266 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-08 AccNo: 0001104659-26-105953 Size: 217 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-08 AccNo: 0001213900-26-098099 Size: 271 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-08 AccNo: 0001193125-26-385355 Size: 619 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Gainers Digital Currency X (NASDAQ:DCX) shares rose 8.6% to $0.63 during Tuesday's after-market session. The company's market cap stands at $200.9 million. GMEX Robotics (NASDAQ:GMEX) stock moved upwards by
Gainers InnovAge Holding (NASDAQ:INNV) shares increased by 10.8% to $11.65 during Tuesday's after-market session. The company's market cap stands at $1.4 billion. The company's, Q4 earnings came out today.
Gainers SUNation Energy (NASDAQ:SUNE) shares moved upwards by 29.9% to $3.08 during Tuesday's after-market session. The company's market cap stands at $15.3 million. Founder Group (NASDAQ:FGL) shares increased
Gainers Sphere 3D (NASDAQ:ANY) stock rose 10.6% to $2.71 during Tuesday's after-market session. The market value of their outstanding shares is at $20.1 million. Arbe Robotics (NASDAQ:ARBE) stock increased by
Filed: 2026-09-08 AccNo: 0001140361-26-035939 Size: 155 KB Item 5.07: Submission of Matters to a Vote of Security Holders
Filed: 2026-09-08 AccNo: 0001756770-26-000095 Size: 1 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits